Le Lézard
Classified in: Health
Subject: AWD

Joule announces 2020 Innovation grant recipients


12 recipients to share $500,000 to develop or scale up projects to improve access to care, innovate and sustain the health care system and improve physician health and wellness

OTTAWA, ON, Jan. 14, 2021 /CNW/ - Joule, a Canadian Medical Association (CMA) subsidiary, today announced the 12 recipients of its 2020 Innovation grant program. The physicians and medical learners from across the country will share $500,000 in funding to develop or expand their respective projects.

Access to care:

Physician health and wellness:

Health care solutions:

Sustainable health care:

Emerging physician innovators:

Since 2016, the Joule Innovation grant program has supported physician-led innovation for CMA members. 2020 marks the fifth and final year the innovation grants will be offered. Moving forward, all granting programs in support of the profession, the health care system and communities will be undertaken through the CMA Foundation, the hub for CMA's strategic granting.

SOURCE Joule


These press releases may also interest you

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...

at 07:23
Straine Dental Management (SDM), a dentist-owned, dentist-led dental services organization (DSO), continues its national expansion with a strategic affiliation with Jolly Family Dental ? North Little Rock, Arkansas. SDM's entry into its 13th state...

at 07:20
Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in...

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...



News published on and distributed by: